I just wonder that whether or not Women’s Health teams can run Duphalac VDO during WH presentation among OB&GYN as the brainstorming during S&OP meeting. Considering that Duphalac can’t either join Women’s Health booth exhibition in MAC (Menopause Academic Conference) or MFM (Maternal Fetal Medicine) in Pattaya, in May – which is the good opportunity to meet expert in these areas.
We were confirmed that Duphalac did have the limitation and restriction to be presented and promoted in Menopause, Pregnant women and of course OB&GYN doctors, No?
If we misunderstood, please clarify. Because if GI team can’t promote Duphalac via OB&GYN due to product restriction, I’m not sure how WH team can?